Literature DB >> 24695654

Acute cardiac tamponade in light-chain amyloidosis.

Mikhail Kuprian1, George Mount.   

Abstract

A 71-year-old woman, with a history of light-chain amyloidosis, presented with a sudden onset dyspnoea. Echocardiography showed a large pericardial effusion with compression of the right atrium and the right ventricle. Right heart catheterisation demonstrated equalisation of her diastolic pressures consistent with cardiac tamponade. Pericardiocentesis revealed a haemmorrhagic exudative effusion with no evidence of malignancy. Bone marrow biopsy and other investigations showed no evidence of multiple myeloma. Her effusion recurred 2 weeks later and repeat pericardiocentesis demonstrated similar findings. She was started on chemotherapy with no further recurrence of pericardial effusion. The patient was unable to tolerate chemotherapy and died 1 year after initial presentation. This case represents a rare manifestation of cardiac amyloidosis and explores the reported aetiologies for cardiac tamponade in the setting of light-chain amyloidosis. Acute and definitive treatments are also discussed.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24695654      PMCID: PMC3987249          DOI: 10.1136/bcr-2013-200248

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  15 in total

1.  High-dose melphalan and peripheral blood stem cell transplantation for light-chain amyloidosis with cardiac involvement.

Authors:  Sumit Madan; Shaji K Kumar; Angela Dispenzieri; Martha Q Lacy; Suzanne R Hayman; Francis K Buadi; David Dingli; S Vincent Rajkumar; William J Hogan; Nelson Leung; Martha Grogan; Morie A Gertz
Journal:  Blood       Date:  2011-12-06       Impact factor: 22.113

2.  Coagulopathy in a patient with nephrotic syndrome.

Authors:  Shari Ghanny; Catherine Ross; Anthony K C Chan; Howard H W Chan
Journal:  Am J Hematol       Date:  2010-09       Impact factor: 10.047

3.  Multiple myeloma with pericardial involvement and cardiac tamponade: a report of three patients.

Authors:  H Rosenbaum; R Hoffman; A Carter; B Brenner; A Markel; Y Ben Arie; J M Rowe
Journal:  Leuk Lymphoma       Date:  1996-12

4.  Outcome of AL amyloidosis after high-dose melphalan and autologous stem cell transplantation: long-term results in a series of 421 patients.

Authors:  Maria Teresa Cibeira; Vaishali Sanchorawala; David C Seldin; Karen Quillen; John L Berk; Laura M Dember; Adam Segal; Frederick Ruberg; Hans Meier-Ewert; Nancy T Andrea; J Mark Sloan; Kathleen T Finn; Gheorghe Doros; Joan Blade; Martha Skinner
Journal:  Blood       Date:  2011-08-09       Impact factor: 22.113

5.  An unusual presentation of plasma cell dyscrasias: cardiac tamponade due to myelomatous infiltration.

Authors:  Mutlu Arat; Vasfi Ulusoy; Taner Demirer; Akin V Uysal; Muhit Ozcan; Süleyman Dinçer; Osman Ilhan; Haluk Koç
Journal:  Leuk Lymphoma       Date:  2002-01

Review 6.  Amyloidosis and bleeding: pathophysiology, diagnosis, and therapy.

Authors:  Christoph Sucker; Gerd Ruediger Hetzel; Bernd Grabensee; Marcus Stockschlaeder; Ruediger E Scharf
Journal:  Am J Kidney Dis       Date:  2006-06       Impact factor: 8.860

Review 7.  Amyloid in the cardiovascular system: a review.

Authors:  I Kholová; H W M Niessen
Journal:  J Clin Pathol       Date:  2005-02       Impact factor: 3.411

8.  A trial of three regimens for primary amyloidosis: colchicine alone, melphalan and prednisone, and melphalan, prednisone, and colchicine.

Authors:  R A Kyle; M A Gertz; P R Greipp; T E Witzig; J A Lust; M Q Lacy; T M Therneau
Journal:  N Engl J Med       Date:  1997-04-24       Impact factor: 91.245

9.  Primary systemic amyloidosis with bloody pericardial effusion.

Authors:  Kensuke Toyama; Hideki Oka; Kenji Obata; Hisao Ogawa
Journal:  Intern Med       Date:  2009-05-15       Impact factor: 1.271

10.  Echocardiographic findings in systemic amyloidosis: spectrum of cardiac involvement and relation to survival.

Authors:  L Cueto-Garcia; G S Reeder; R A Kyle; D L Wood; J B Seward; J Naessens; K P Offord; P R Greipp; W D Edwards; A J Tajik
Journal:  J Am Coll Cardiol       Date:  1985-10       Impact factor: 24.094

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.